お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:ウイルス学・細菌学の世界市場:技術、疾患、エンドユーザー、地域別、 競合、予測および機会(2025年)
市場調査レポート
商品コード
953899

ウイルス学・細菌学の世界市場:技術、疾患、エンドユーザー、地域別、 競合、予測および機会(2025年)

Global Virology and Bacteriology Market, By Technology, By Disease, By End User, By Region, Competition, Forecast & Opportunities, 2025

出版日: | 発行: TechSci Research | ページ情報: 英文 126 Pages | 納期: お問合せ

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.22円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

ウイルス学・細菌学の世界市場:技術、疾患、エンドユーザー、地域別、 競合、予測および機会(2025年)
出版日: 2020年08月01日
発行: TechSci Research
ページ情報: 英文 126 Pages
納期: お問合せ
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のウイルス学・細菌学市場は、2021年から2025年の間に約12%のCAGRで成長すると予測されます。 同市場の成長は、ウイルスおよび細菌感染の影響を受ける人口の増加によって推進されています。さらに、世界の各政府によるヘルスケアインフラストラクチャへのさらなる投資は、市場成長にプラスの影響を与えています。また、研究開発活動における継続的な技術革新は、今後数年間の市場の成長をさらに強化すると見込まれています。

当レポートは、世界のウイルス学・細菌学市場について調査しており、市場規模・予測、シェアや動向、成長要因、技術・疾患・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 製品の概要

第2章 調査手法

第3章 COVID-19の影響

第4章 エグゼクティブサマリー

第5章 VOC (顧客の声)

第6章 市場の展望

  • 市場規模と予測
    • 売上別
  • 市場シェアと予測
    • 技術別(分子診断、イムノアッセイ、画像診断、情報技術)
    • 疾患別(呼吸器系、尿路、および血流疾患、胃腸疾患・歯周疾患、性感染症)
    • エンドユーザー別(クリニック、病院、診断センター、研究、血液銀行)
    • 企業別(2019)
    • 地域別
  • 市場魅力指数

第7章 アジア太平洋地域

第8章 欧州

第9章 北米

第10章 南米

第11章 中東・アフリカ

第12章 市場力学

  • 成長要因
  • 課題

第13章 市場動向

第14章 特許分析

第15章 競合情勢

  • 富士レビオ株式会社
  • Cepheid Inc.
  • DiaSorin S.p.A.
  • Bio-Rad Laboratories Inc.
  • Thermo Fisher Scientific Inc.
  • Scienion AG
  • Grifols S.A.
  • Qiagen N.V.
  • 栄研化学株式会社
  • Sequenom Inc.
  • bioMerieux SA
  • Siemens AG
  • Hologic Inc.
  • Diamedix Corporation
  • Leica Biosystems Nussloch GmbH
  • F. Hoffmann-La Roche AG
  • Abbott Laboratories
  • GSK Biologicals SA

第16章 戦略的提言

図表

List of Figures

  • Figure 1: Global Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 2: Global Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 3: Global Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 4: Global Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 5: Global Virology and Bacteriology Market Size, By Company (USD Million), 2015-2025F
  • Figure 6: Global Virology and Bacteriology Market Size, By Region (USD Million), 2015-2025F
  • Figure 7: Global Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 8: North America Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 9: North America Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 10: North America Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 11: North America Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 12: North America Virology and Bacteriology Market Size, By Country (USD Million), 2015-2025F
  • Figure 13: North America Virology and Bacteriology Market Size Attractiveness Index, By Country, By Value, 2015-2025F
  • Figure 14: North America Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 15: United States Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 16: United States Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 17: United States Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 18: United States Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 19: United States Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 20: Canada Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 21: Canada Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 22: Canada Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 23: Canada Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 24: Canada Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 25: Mexico Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 26: Mexico Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 27: Mexico Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 28: Mexico Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 29: Mexico Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 30: Europe Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 31: Europe Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 32: Europe Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 33: Europe Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 34: Europe Virology and Bacteriology Market Size, By Country (USD Million), 2015-2025F
  • Figure 35: Europe Virology and Bacteriology Market Size Attractiveness Index, By Country, By Value, 2015-2025F
  • Figure 36: Europe Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 37: France Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 38: France Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 39: France Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 40: France Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 41: France Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 42: Germany Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 43: Germany Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 44: Germany Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 45: Germany Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 46: Germany Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 47: Italy Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 48: Italy Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 49: Italy Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 50: Italy Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 51: Italy Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 52: Spain Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 53: Spain Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 54: Spain Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 55: Spain Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 56: Spain Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 57: United Kingdom Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 58: United Kingdom Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 59: United Kingdom Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 60: United Kingdom Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 61: United Kingdom Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 62: Russia Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 63: Russia Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 64: Russia Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 65: Russia Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 66: Russia Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 67: Asia-Pacific Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 68: Asia-Pacific Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 69: Asia-Pacific Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 70: Asia-Pacific Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 71: Asia-Pacific Virology and Bacteriology Market Size, By Country (USD Million), 2015-2025F
  • Figure 72: Asia-Pacific Virology and Bacteriology Market Size Attractiveness Index, By Country, By Value, 2015-2025F
  • Figure 73: Asia-Pacific Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 74: China Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 75: China Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 76: China Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 77: China Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 78: China Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 79: India Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 80: India Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 81: India Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 82: India Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 83: India Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 84: Japan Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 85: Japan Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 86: Japan Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 87: Japan Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 88: Japan Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 89: South Korea Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 90: South Korea Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 91: South Korea Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 92: South Korea Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 93: South Korea Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 94: Australia Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 95: Australia Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 96: Australia Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 97: Australia Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 98: Australia Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 99: Singapore Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 100: Singapore Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 101: Singapore Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 102: Singapore Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 103: Singapore Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 104: Middle East and Africa Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 105: Middle East and Africa Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 106: Middle East and Africa Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 107: Middle East and Africa Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 108: Middle East and Africa Virology and Bacteriology Market Size, By Country (USD Million), 2015-2025F
  • Figure 109: Middle East and Africa Virology and Bacteriology Market Size Attractiveness Index, By Country, By Value, 2015-2025F
  • Figure 110: Middle East and Africa Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 111: South Africa Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 112: South Africa Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 113: South Africa Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 114: South Africa Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 115: South Africa Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 116: Saudi Arabia Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 117: Saudi Arabia Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 118: Saudi Arabia Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 119: Saudi Arabia Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 120: Saudi Arabia Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 121: Kuwait Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 122: Kuwait Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 123: Kuwait Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 124: Kuwait Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 125: Kuwait Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 126: UAE Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 127: UAE Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 128: UAE Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 129: UAE Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 130: UAE Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 131: South America Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 132: South America Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 133: South America Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 134: South America Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 135: South America Virology and Bacteriology Market Size, By Country (USD Million), 2015-2025F
  • Figure 136: South America Virology and Bacteriology Market Size Attractiveness Index, By Country, By Value, 2015-2025F
  • Figure 137: South America Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 138: Brazil Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 139: Brazil Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 140: Brazil Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 141: Brazil Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 142: Brazil Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 143: Argentina Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 144: Argentina Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 145: Argentina Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 146: Argentina Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 147: Argentina Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
  • Figure 148: Colombia Virology and Bacteriology Market Size, By Value (USD Million), 2015-2025F
  • Figure 149: Colombia Virology and Bacteriology Market Size, By Technology (USD Million), 2015-2025F
  • Figure 150: Colombia Virology and Bacteriology Market Size, By Disease (USD Million), 2015-2025F
  • Figure 151: Colombia Virology and Bacteriology Market Size, By End-User (USD Million), 2015-2025F
  • Figure 152: Colombia Virology and Bacteriology Market Size Attractiveness Index, By Technology, By Value, 2015-2025F
目次
Product Code: 4700

Title:
Global Virology and Bacteriology Market, By Technology (Molecular Diagnostics, Immunoassays, Diagnostic Imaging, Information Technology), By Disease (Respiratory System, Urinary Tract, And Bloodstream Diseases, Gastrointestinal, Sexually Transmitted Diseases), By End User (Clinics, Hospitals, Diagnostic Centers, Research Laboratories, And Blood Banks), By Region, Competition, Forecast & Opportunities, 2025.

Global virology and bacteriology market is expected to grow at a CAGR of around 12% during 2021 - 2025. The global virology and bacteriology market is driven by rising population getting affected by viral and bacterial infections. Moreover, governments across the globe are investing more on healthcare infrastructure, which is positively impacting the market growth. Also, continuous technological innovations in research and development activities is further expected to bolster the growth of market over the next few years.

The global virology and bacteriology market is segmented based on technology, disease, end user, company, and region. Based on technology, the market can be categorized into molecular diagnostics, immunoassays, diagnostic imaging, and information technology. Out of these, the molecular diagnostics segment dominated the market in 2019 and is expected to maintain its leading position during the forecast period as well. This can be ascribed to the fact that this technology allows the detection of lower amount of infectious agents, thereby detecting the infection at an early stage than was previously possible.

Major players operating in the global virology and bacteriology market include Fujirebio Diagnostics Inc., Cepheid Inc., DiaSorin S.p.A., Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Scienion AG, Grifols S.A., Qiagen N.V., Eiken Chemical Co Ltd, Sequenom Inc., bioMerieux SA, Siemens AG, Hologic Inc., Diamedix Corporation, Leica Biosystems Nussloch GmbH, F. Hoffmann-La Roche AG, Abbott Laboratories, GSK Biologicals SA among others. The companies are developing advanced technologies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers, acquisitions, collaborations and partnerships.

Years considered for this report:

Historical Years: 2015 - 2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021 - 2025

Objective of the Study:

  • To analyze and estimate the market size of global virology and bacteriology market from 2015 to 2018.
  • To estimate and forecast the market size of global virology and bacteriology market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast global virology and bacteriology market based on technology, disease, end user, company and regional distribution.
  • To identify dominant region or segment in the global virology and bacteriology market.
  • To identify drivers and challenges for global virology and bacteriology market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global virology and bacteriology market.
  • To identify and analyze the profile of leading players operating in global virology and bacteriology market.
  • To identify key sustainable strategies adopted by market players in global virology and bacteriology market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of market players operating across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the hospitals/clinics which could not be identified due to the limitations of secondary research. TechSci Research analyzed the presence of all major players across the globe.

TechSci Research calculated the market size of global virology and bacteriology market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Virology and bacteriology hospitals/clinics, laboratories and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to virology and bacteriology market
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals/clinics, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global virology and bacteriology market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Technology:

Molecular Diagnostics

Immunoassays

Diagnostic Imaging

Information Technology

  • Market, By Disease:

Respiratory System

Urinary Tract, And Bloodstream Diseases

Gastrointestinal and Periodontal Diseases

Sexually Transmitted Diseases

  • Market, By Disease:

Clinics

Hospitals

Diagnostic Centers

Research Laboratories

Blood Banks

  • Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Singapore

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • Kuwait
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global virology and bacteriology market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Virology and Bacteriology Market

4. Executive Summary

5. Voice of Customer

6. Global Virology and Bacteriology Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology (Molecular Diagnostics, Immunoassays, Diagnostic Imaging, Information Technology)
    • 6.2.2. By Disease (Respiratory System, Urinary Tract, And Bloodstream Diseases; Gastrointestinal and Periodontal Diseases; Sexually Transmitted Diseases)
    • 6.2.3. By End User (Clinics, Hospitals, Diagnostic Centers, Research Laboratories, And Blood Banks)
    • 6.2.4. By Company (2019)
    • 6.2.5. By Region
  • 6.3. Market Attractiveness Index

7. Asia-Pacific Virology and Bacteriology Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By Disease
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Asia-Pacific: Country Analysis
    • 7.3.1. China Virology and Bacteriology Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technology
        • 7.3.1.2.2. By Disease
        • 7.3.1.2.3. By End User
    • 7.3.2. India Virology and Bacteriology Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technology
        • 7.3.2.2.2. By Disease
        • 7.3.2.2.3. By End User
    • 7.3.3. Japan Virology and Bacteriology Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technology
        • 7.3.3.2.2. By Disease
        • 7.3.3.2.3. By End User
    • 7.3.4. South Korea Virology and Bacteriology Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technology
        • 7.3.4.2.2. By Disease
        • 7.3.4.2.3. By End User
    • 7.3.5. Australia Virology and Bacteriology Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technology
        • 7.3.5.2.2. By Disease
        • 7.3.5.2.3. By End User
    • 7.3.6. Singapore Virology and Bacteriology Market Outlook
      • 7.3.6.1. Market Size & Forecast
        • 7.3.6.1.1. By Value
      • 7.3.6.2. Market Share & Forecast
        • 7.3.6.2.1. By Technology
        • 7.3.6.2.2. By Disease
        • 7.3.6.2.3. By End User

8. Europe Virology and Bacteriology Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Disease
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Europe: Country Analysis
    • 8.3.1. France Virology and Bacteriology Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technology
        • 8.3.1.2.2. By Disease
        • 8.3.1.2.3. By End User
    • 8.3.2. Germany Virology and Bacteriology Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technology
        • 8.3.2.2.2. By Disease
        • 8.3.2.2.3. By End User
    • 8.3.3. United Kingdom Virology and Bacteriology Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technology
        • 8.3.3.2.2. By Disease
        • 8.3.3.2.3. By End Use
    • 8.3.4. Italy Virology and Bacteriology Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technology
        • 8.3.4.2.2. By Disease
        • 8.3.4.2.3. By End User
    • 8.3.5. Spain Virology and Bacteriology Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technology
        • 8.3.5.2.2. By Disease
        • 8.3.5.2.3. By End User
    • 8.3.6. Russia Virology and Bacteriology Market Outlook
      • 8.3.6.1. Market Size & Forecast
        • 8.3.6.1.1. By Value
      • 8.3.6.2. Market Share & Forecast
        • 8.3.6.2.1. By Technology
        • 8.3.6.2.2. By Disease
        • 8.3.6.2.3. By End User

9. North America Virology and Bacteriology Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Disease
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. North America: Country Analysis
    • 9.3.1. United States Virology and Bacteriology Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technology
        • 9.3.1.2.2. By Disease
        • 9.3.1.2.3. By End User
    • 9.3.2. Mexico Virology and Bacteriology Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technology
        • 9.3.2.2.2. By Disease
        • 9.3.2.2.3. By End User
    • 9.3.3. Canada Virology and Bacteriology Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technology
        • 9.3.3.2.2. By Disease
        • 9.3.3.2.3. By End User

10. South America Virology and Bacteriology Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technology
    • 10.2.2. By Disease
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Virology and Bacteriology Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technology
        • 10.3.1.2.2. By Disease
        • 10.3.1.2.3. By End User
    • 10.3.2. Argentina Virology and Bacteriology Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technology
        • 10.3.2.2.2. By Disease
        • 10.3.2.2.3. By End User
    • 10.3.3. Colombia Virology and Bacteriology Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technology
        • 10.3.3.2.2. By Disease
        • 10.3.3.2.3. By End Use

11. Middle East and Africa Virology and Bacteriology Market Outlook

  • 11.1. Market Size & Forecast
    • 11.1.1. By Value
  • 11.2. Market Share & Forecast
    • 11.2.1. By Technology
    • 11.2.2. By Disease
    • 11.2.3. By End User
    • 11.2.4. By Country
  • 11.3. MEA: Country Analysis
    • 11.3.1. South Africa Virology and Bacteriology Market Outlook
      • 11.3.1.1. Market Size & Forecast
        • 11.3.1.1.1. By Value
      • 11.3.1.2. Market Share & Forecast
        • 11.3.1.2.1. By Technology
        • 11.3.1.2.2. By Disease
        • 11.3.1.2.3. By End User
    • 11.3.2. Saudi Arabia Virology and Bacteriology Market Outlook
      • 11.3.2.1. Market Size & Forecast
        • 11.3.2.1.1. By Value
      • 11.3.2.2. Market Share & Forecast
        • 11.3.2.2.1. By Technology
        • 11.3.2.2.2. By Disease
        • 11.3.2.2.3. By End User
    • 11.3.3. UAE Virology and Bacteriology Market Outlook
      • 11.3.3.1. Market Size & Forecast
        • 11.3.3.1.1. By Value
      • 11.3.3.2. Market Share & Forecast
        • 11.3.3.2.1. By Technology
        • 11.3.3.2.2. By Disease
        • 11.3.3.2.3. By End User
    • 11.3.4. Kuwait Virology and Bacteriology Market Outlook
      • 11.3.4.1. Market Size & Forecast
        • 11.3.4.1.1. By Value
      • 11.3.4.2. Market Share & Forecast
        • 11.3.4.2.1. By Technology
        • 11.3.4.2.2. By Disease
        • 11.3.4.2.3. By End User

12. Market Dynamics

  • 12.1. Drivers
  • 12.2. Challenges

13. Market Trends & Developments

14. Patent Analysis

15. Competitive Landscape

  • 15.1. Fujirebio Diagnostics Inc.
  • 15.2. Cepheid Inc.
  • 15.3. DiaSorin S.p.A.
  • 15.4. Bio-Rad Laboratories Inc.
  • 15.5. Thermo Fisher Scientific Inc.
  • 15.6. Scienion AG
  • 15.7. Grifols S.A.
  • 15.8. Qiagen N.V.
  • 15.9. Eiken Chemical Co. Ltd.
  • 15.10. Sequenom Inc.
  • 15.11. bioMerieux SA
  • 15.12. Siemens AG
  • 15.13. Hologic Inc.
  • 15.14. Diamedix Corporation
  • 15.15. Leica Biosystems Nussloch GmbH
  • 15.16. F. Hoffmann-La Roche AG
  • 15.17. Abbott Laboratories
  • 15.18. GSK Biologicals SA

16. Strategic Recommendations

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.